In vitro susceptibility of porcine respiratory pathogens to tilmicosin

Journal of Veterinary Diagnostic Investigation

Volumn 12, Issue 6, 2000, Pages 541-546

  DeRosa, D C ^a   Veenhuizen, M F ^a   Bade, D J ^b   Shryock, T R ^a  

^a ELANCO ANIMAL HEALTH   (United States)

^b Colorado Anim Res Entpr Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MACROLIDE; TILMICOSIN; TYLOSIN;

ACTINOBACILLUS; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIUM; BORDETELLA BRONCHISEPTICA; DRUG EFFECT; ERYSIPELOTHRIX; HAEMOPHILUS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PASTEURELLA MULTOCIDA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; SWINE; SWINE DISEASE;

ACTINOBACILLUS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BORDETELLA BRONCHISEPTICA; ERYSIPELOTHRIX; HAEMOPHILUS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PASTEURELLA MULTOCIDA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS; SWINE; SWINE DISEASES; TYLOSIN;

EID: 0034331456     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870001200608     Document Type: Article

References (14)

1. Backstrom L, McDonald J, Collins MT, et al.: 1994, Efficacy of tilmicosin and a combination of tylosin and sulfamethazine, for control of swine atropic rhinitis involving infection with toxigenic Pasteurella multocida type D. Swine Health Prod 2(4):11-14.
2. Clark LK, Wu CC, Van Alstine WG, Knox KE: 1998, Evaluation of the effectiveness of a macrolide antibiotic on reduction of respiratory pathogens in 12-day and 21-day weaned pigs. Swine Health Prod 6(6):257-262.
3. Diarra MS, Malouin F, Jacques M: 1999, Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Int J Antimicrob Agents 12:229-237
4. Inamoto T, Dikuchi K, Iijima H, Kawashima, et al.: 1994, Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions m swine. J Vet Med Sci 56:917-921.
5. Jordan FTW, Horrocks BK: 1996, The minimum inhibitory concentration of tilmicosin and tylosin for Mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. Avian Dis 40:326-334.
6. MacInnes JI, Desrosiers R: 1999, Agents of the "suis-ide" diseases of swine: Actinobacillus suis, Haemophilus parasuis, and Streptococcus suis. Can J Vet Res 63:83-89.
7. Merill JK, Tonkinson LV: 1989, The effectiveness of Micotil for the treatment of bovine respiratory disease. Bovine Pract 24:26-28.
8. Moore GM, Basson R, Tonkinson LV: 1996, Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumoniae caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Am J Vet Res 57:224-228.
9. Moore GM, Mowery DH, Tonkinson LV, Lechtenberg KF, et al.: 1996, Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine. Am J Vet Res 57:220-223.
10. National Committee on Clinical Laboratory Standards (NCCLS): 1997, Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, tentative standard M31-T. NCCLS, Villanova, PA.
11. Ose EE: 1987, In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic. J Antibiot 40:190-194.
12. Salmon SA, Watts JL, Hoffman LJ, et al.: 1995, Comparisons of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. J Clin Microbiol 33:2435-2444.
13. Scorneaux B, Shryock TR: 1998, Intracellular accumulation, subcellular distribution and efflux of tilmicosin in swine phagocytes. J Vet Pharmacol Ther 21:257-268.
14. Veenhuizen MF, Underwood MJ: 1998, Management of nursery pig health with respiratory feed antibiotics. Large Anim Pract May/June:33-37.